A novel diagnostic measure of platelet-specific antibody in immune thrombocytopenia.
- Author:
	        		
		        		
		        		
			        		Xue-li ZHOU
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Shi YAN
			        		
			        		;
		        		
		        		
		        		
			        		Qiang LI
			        		
			        		;
		        		
		        		
		        		
			        		Peng LI
			        		
			        		;
		        		
		        		
		        		
			        		Ze-ping ZHOU
			        		
			        		;
		        		
		        		
		        		
			        		Ren-chi YANG
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Autoantibodies; analysis; immunology; Enzyme-Linked Immunosorbent Assay; methods; Female; Humans; Male; Platelet Glycoprotein GPIIb-IIIa Complex; immunology; Platelet Glycoprotein GPIb-IX Complex; immunology; Platelet Membrane Glycoproteins; immunology; Sensitivity and Specificity; Thrombocytopenia; diagnosis; immunology
 - From: Chinese Journal of Hematology 2012;33(3):200-203
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo detect the platelet glycoprotein-specific antibodies in serum of thrombocytopenia patients and evaluate its diagnostic value for immune thrombocytopenia.
METHODAnti-GPIIb/IIIa, GPIb/IX and GPIa/IIa antibodies were assayed by ELISA kit (PAKUTO) in patients with thrombocytopenia.
RESULTSThe sensitivity and specificity of PAKAUTO in immune thrombocytopenia were 44.0% and 95.7%, respectively. The values of positive and negative predictions were 98.0% and 26.2%, respectively. Among those PAKAUTO positive patients, positive rates of GPIIb/IIIa, GPIa/IIa and GPIb/IX were 87%, 35% and 10%, respectively. The positive rate of patients not received immune suppressive agents (58.5%) was significantly higher than those received immune suppressive agents (26.9%) (P < 0.01). The positive rate of patients with platelet count ≤ 20 × 10(9)/L (51.6%) was significantly higher than those with platelet count > 20 × 10(9)/L (27.8%) (P < 0.01). The positive rate of patients with secondary immune thrombocytopenia (66.7%) was significantly higher than those with primary immune thrombocytopenia (41.7%) (P < 0.05).
CONCLUSIONThe highly specific method (PAKAUTO) could effectively differentiate immune or non-immune thrombocytopenia and be applied to diagnosis of immune thrombocytopenia.
 
            